Hou B, Zhou L, Wang H, Saeed M, Wang D, Xu Z, et al
Sparkling water with bitters, non-alcoholic craft beverages, herbal tea, or kombucha can fill the glass in your hand without the alcohol in your bloodstream
Okava Pharmaceuticals developed this exenatide (GLP-1 drug) implant, OKV-119, using the NanoPortal platform of its partner, Vivani Medical Inc
Partnering with an experienced medical billing services company can streamline claims, maintain compliance, and boost revenue performance
Compounded GLP-1 medications are labeled clearly as not FDA-approved, without framing them as equivalents to branded drugs
Some patients benefit from faster dose escalation because their genetic profile suggests excellent receptor responsiveness, while others may optimize better with a slower, steadier approach